
    
      This is a three-period crossover double-blinded study. 8 subjects will be recruited and they
      will attend 3 study sessions after informed written and verbal consent. They would have
      dexmedetomidine administered via different rout each time, intravenous, intranasal via
      dripping or intranasal via atomizer. Blood samples are collect to determine bioavailability
      of each mode of drug delivery.
    
  